Northern Trust’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $946K | Buy |
|
|||||
|
2025
Q1 | $628K | Sell |
|
|||||
|
2024
Q4 | $1.33M | Sell |
|
|||||
|
2024
Q3 | $2.85M | Buy |
|
|||||
|
2024
Q2 | $2.42M | Buy |
|
|||||
|
2024
Q1 | $5.26M | Buy |
|
|||||
|
2023
Q4 | $2.65M | Sell |
|
|||||
|
2023
Q3 | $2.65M | Sell |
|
|||||
|
2023
Q2 | $5.96M | Buy |
|
|||||
|
2023
Q1 | $4.48M | Buy |
|
|||||
|
2022
Q4 | $7.7M | Sell |
|
|||||
|
2022
Q3 | $17.2M | Sell |
|
|||||
|
2022
Q2 | $19.2M | Sell |
|
|||||
|
2022
Q1 | $30.2M | Sell |
|
|||||
|
2021
Q4 | $47.5M | Sell |
|
|||||
|
2021
Q3 | $48.8M | Sell |
|
|||||
|
2021
Q2 | $76.8M | Buy |
|
|||||
|
2021
Q1 | $72.7M | Sell |
|
|||||
|
2020
Q4 | $81.2M | Sell |
|
|||||
|
2020
Q3 | $36.7M | Buy |
|
|||||
|
2020
Q2 | $30.1M | Buy |
|
|||||
|
2020
Q1 | $17.8M | Buy |
|
|||||
|
2019
Q4 | $15.5M | Buy |
|
|||||
|
2019
Q3 | $10.8M | Sell |
|
|||||
|
2019
Q2 | $15.3M | Buy |
|
|||||
|
2019
Q1 | $13.2M | Buy |
|
|||||
|
2018
Q4 | $9.44M | Buy |
|
|||||
|
2018
Q3 | $10.2M | Buy |
|
|||||
|
2018
Q2 | $6.44M | Buy |
|
|||||
|
2018
Q1 | $4.85M | Buy |
|
|||||
|
2017
Q4 | $2.37M | Sell |
|
|||||
|
2017
Q3 | $1.56M | Buy |
|
|||||
|
2017
Q2 | $1.19M | Buy |
|
|||||
|
2017
Q1 | $157K | Sell |
|
|||||
|
2016
Q4 | $100K | Buy |
|
|||||
|
2016
Q3 | $121K | Buy |
|
|||||
|
2016
Q2 | $43K | Hold |
|
|||||
|
2016
Q1 | $46K | Hold |
|
|||||
|
2015
Q4 | $86K | Hold |
|
|||||
|
2015
Q3 | $136K | Sell |
|
|||||
|
2015
Q2 | $191K | Buy |
|